In NB, a pediatric cancer of the sympathetic nervous system, MYCN-amplification is strongly correlated with poor prognosis and advanced tumor stage, and these tumors are often resistant to multimodal therapy [11], [12]. The gene discussed is MYCN; the disease is neoplasm.